Effects of hepatitis B virus infection and antiviral therapy on the clinical prognosis of nasopharyngeal carcinoma. [electronic resource]
- Cancer medicine 01 2020
- 541-551 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2045-7634
10.1002/cam4.2715 doi
Antiviral Agents--therapeutic use Female Follow-Up Studies Hepatitis B--complications Hepatitis B virus--drug effects Humans Male Middle Aged Nasopharyngeal Carcinoma--epidemiology Nasopharyngeal Neoplasms--epidemiology Prognosis Retrospective Studies Survival Rate